Biologic Patent Protection: When Do Biosimilars Enter the Market?
Learn how the BPCIA and the 'patent dance' determine when biosimilars enter the U.S. market and why biologic patent protection differs from traditional generics.
Learn how the BPCIA and the 'patent dance' determine when biosimilars enter the U.S. market and why biologic patent protection differs from traditional generics.
Explore the link between anticholinergic medications and dementia. Learn about the 'anticholinergic burden,' high-risk drugs, and how to find safer alternatives.
Learn which medications to avoid during pregnancy to protect fetal health, discover safe alternatives for common pains, and understand the latest FDA safety warnings.
Learn how to pack a travel medication kit for common conditions. This guide covers essential meds, wound care, prescription safety, and destination-specific tips.
Explore Patent Term Restoration, a legal tool under the Hatch-Waxman Act that extends drug patent exclusivity. Learn eligibility, calculations, and economic impacts.
Learn how soy products impact thyroid medication absorption. Practical guide on timing, specific foods to watch, and stabilizing TSH levels with levothyroxine.
Explore how International ICH Guidelines standardize medication safety globally. Learn about the 5-step process, key safety pillars, and recent 2024 updates impacting FDA and EMA regulations.
Drug shortages are disrupting care for millions of patients, forcing delays, substitutions, and dangerous errors. From cancer drugs to antibiotics, when medications vanish, lives hang in the balance.
The FDA uses priority and standard review timelines to speed up or manage generic drug approvals. Priority review cuts approval time from 10 to 8 months for first generics, shortage drugs, or improved formulations - and now includes incentives for U.S. manufacturing.
Generic drug shortages are caused by fragile manufacturing, global supply chains, and low profit margins. With most production overseas and no safety buffer, even small disruptions lead to nationwide shortages - putting patients at risk.
Pharmacogenomic testing for CYP2C19 and CYP2D6 genes helps predict how your body metabolizes SSRIs, reducing side effects and avoiding trial-and-error prescribing. Learn how your genes impact antidepressant tolerance and effectiveness.
Combination cold and allergy meds like Zyrtec-D and Claritin-D seem convenient, but they carry real risks-high blood pressure, drowsiness, and overdose. Learn what you need to know before taking them.